Icecure Medical(ICCM)
$0.74-0.05 (-6.08%)
ICCM
Icecure Medical financials statements
$0.74
At close:-0.05 (-6.08%)
Want to see ICCM full AI Analyst Report?
Icecure Medical (ICCM) Ratios
361 Followers
Icecure Medical Ratios
ICCM's free cash flow for Q2 2026 was $-3.89M. For the 2026 fiscal year, ICCM's free cash flow was decreased by $-10.00K and operating cash flow was $-3.88M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Mar 24 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.61 | 1.95 | 3.66 | 6.49 | 7.54 |
| Quick Ratio | 2.07 | 1.59 | 3.08 | 5.83 | 7.06 |
| Cash Ratio | 1.84 | 1.37 | 2.72 | 5.46 | 6.37 |
| Solvency Ratio | -3.05 | -2.64 | -3.37 | -3.56 | -1.87 |
| Operating Cash Flow Ratio | -3.02 | -2.28 | -3.23 | -3.30 | -3.14 |
| Short-Term Operating Cash Flow Coverage | 0.00 | -42.16 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ 7.77M | $ 5.08M | $ 9.94M | $ 23.36M | $ 25.00M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.02 | 0.04 | 0.04 | 0.02 | 0.03 |
| Debt-to-Equity Ratio | 0.02 | 0.07 | 0.05 | 0.02 | 0.03 |
| Debt-to-Capital Ratio | 0.02 | 0.06 | 0.05 | 0.02 | 0.03 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.53 | 1.82 | 1.35 | 1.19 | 1.20 |
| Debt Service Coverage Ratio | 0.00 | -51.56 | 0.00 | -69.00 | -56.12 |
| Interest Coverage Ratio | 0.00 | 0.00 | 0.00 | -70.04 | -56.87 |
| Debt to Market Cap | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.10 | 0.27 | 0.01 | 0.02 | 0.04 |
| Net Debt to EBITDA | 0.59 | 0.46 | 0.65 | 1.40 | 2.57 |
| Profitability Margins | |||||
| Gross Profit Margin | 36.28% | 44.09% | 40.26% | 46.84% | 53.04% |
| EBIT Margin | -446.70% | -476.94% | -482.38% | -542.59% | -234.99% |
| EBITDA Margin | -437.97% | -466.85% | -472.38% | -534.55% | -231.92% |
| Operating Profit Margin | -446.70% | -476.94% | -482.38% | -542.59% | -234.99% |
| Pretax Profit Margin | -445.61% | -465.45% | -453.76% | -550.34% | -239.13% |
| Net Profit Margin | -445.61% | -465.45% | -453.76% | -558.09% | -243.26% |
| Continuous Operations Profit Margin | -445.61% | -465.45% | -453.76% | -550.34% | -239.13% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 101.41% | 101.73% |
| EBT Per EBIT | 99.75% | 97.59% | 94.07% | 101.43% | 101.76% |
| Return on Assets (ROA) | -108.42% | -121.80% | -89.29% | -57.03% | -31.18% |
| Return on Equity (ROE) | -166.36% | -221.97% | -120.46% | -67.72% | -37.34% |
| Return on Capital Employed (ROCE) | -166.53% | -222.26% | -124.22% | -64.75% | -34.41% |
| Return on Invested Capital (ROIC) | -162.86% | -204.96% | -122.05% | -64.33% | -34.14% |
| Return on Tangible Assets | -108.42% | -121.80% | -89.29% | -57.03% | -31.18% |
| Earnings Yield | -38.82% | -27.37% | -30.00% | -30.01% | -11.56% |
| Efficiency Ratios | |||||
| Receivables Turnover | 10.21 | 14.89 | 31.35 | 8.43 | 5.37 |
| Payables Turnover | 2.49 | 1.49 | 3.84 | 2.30 | 2.21 |
| Inventory Turnover | 0.82 | 0.93 | 0.85 | 0.57 | 0.99 |
| Fixed Asset Turnover | 2.74 | 1.85 | 1.47 | 1.52 | 2.54 |
| Asset Turnover | 0.24 | 0.26 | 0.20 | 0.10 | 0.13 |
| Working Capital Turnover Ratio | 0.52 | 0.42 | 0.19 | 0.12 | 0.26 |
| Cash Conversion Cycle | 334.47 | 174.48 | 347.13 | 520.25 | 269.76 |
| Days of Sales Outstanding | 35.75 | 24.51 | 11.64 | 43.30 | 68.01 |
| Days of Inventory Outstanding | 445.02 | 394.36 | 430.47 | 635.86 | 367.25 |
| Days of Payables Outstanding | 146.31 | 244.39 | 94.99 | 158.91 | 165.50 |
| Operating Cycle | 480.77 | 418.87 | 442.11 | 679.16 | 435.26 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -6.88 | -7.41 | -0.27 | -0.39 | -0.44 |
| Free Cash Flow Per Share | -6.89 | -7.45 | -0.28 | -0.41 | -0.46 |
| Dividend Paid and CapEx Coverage Ratio | -404.83 | -176.94 | -26.09 | -16.04 | -23.65 |
| Capital Expenditure Coverage Ratio | -404.83 | -176.94 | -26.09 | -16.04 | -23.65 |
| Operating Cash Flow Coverage Ratio | -67.16 | -27.37 | -20.90 | -23.94 | -13.87 |
| Operating Cash Flow to Sales Ratio | -4.31 | -3.82 | -3.88 | -4.63 | -3.05 |
| Free Cash Flow Yield | -37.67% | -22.58% | -26.62% | -26.46% | -15.09% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -2.58 | -3.67 | -3.33 | -3.33 | -8.65 |
| Price-to-Sales (P/S) Ratio | 11.48 | 17.01 | 15.12 | 18.60 | 21.04 |
| Price-to-Book (P/B) Ratio | 4.28 | 8.11 | 4.01 | 2.26 | 3.23 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -2.65 | -4.43 | -3.76 | -3.78 | -6.63 |
| Price-to-Operating Cash Flow Ratio | -2.66 | -4.45 | -3.90 | -4.01 | -6.91 |
| Price-to-Earnings Growth (PEG) Ratio | 0.12 | 0.59 | 0.10 | -0.10 | -0.35 |
| Enterprise Value Multiple | -2.03 | -3.18 | -2.55 | -2.08 | -6.50 |
| Enterprise Value | 30.10M | 48.86M | 38.90M | 34.31M | 62.36M |
| EV to EBITDA | -2.03 | -3.18 | -2.55 | -2.08 | -6.50 |
| EV to Sales | 8.91 | 14.85 | 12.05 | 11.12 | 15.07 |
| EV to Free Cash Flow | -2.06 | -3.87 | -2.99 | -2.26 | -4.75 |
| EV to Operating Cash Flow | -2.07 | -3.89 | -3.11 | -2.40 | -4.95 |
| Tangible Book Value Per Share | 4.27 | 4.07 | 0.27 | 0.69 | 0.94 |
| Shareholders’ Equity Per Share | 4.27 | 4.07 | 0.27 | 0.69 | 0.94 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 1.59 | 1.94 | 0.07 | 0.08 | 0.14 |
| Net Income Per Share | -7.10 | -9.03 | -0.32 | -0.47 | -0.35 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.01 | 1.02 |
| Interest Burden | 1.00 | 0.98 | 0.94 | 1.01 | 1.02 |
| Research & Development to Revenue | 2.20 | 2.16 | 2.56 | 2.96 | 1.42 |
| SG&A to Revenue | 2.63 | 3.05 | 1.29 | 1.90 | 1.00 |
| Stock-Based Compensation to Revenue | 0.41 | 0.26 | 0.41 | 0.60 | 0.08 |
| Income Quality | 0.97 | 0.82 | 0.85 | 0.84 | 1.27 |
Currency in USD
